The co-crystal of succinic acid with imidazolidin-2-one was mechanochemically prepared and its structure was studied by powder and single-crystal X-ray diffraction. This compound crystallizes in the triclinic system with space group P-1. The molecular structure and crystal packing are stabilized mainly by intermolecular O--H···O and N--H···O hydrogen bonds interactions, forming a supramolecular assembly with bi-dimensional hydrogen bond networks along the [110] diagonal joined by C44(22) chains and R22(8) amide-acid dimers which running along the ba plane. These hydrogen bonds contribute to the stabilization of the crystal structure that packs with an efficiency of 69.1 % in a planar sheet structure similarly to the even diacid co-crystals ...
The combination of racemic praziquantel, (<i>RS</i>)-PZQ, with aliphatic dicarboxylic acids of the h...
R factor = 0.034; wR factor = 0.095; data-to-parameter ratio = 19.0. The title compound, C12H14N2O3S...
Diffusion of acetonitrile into an aqueous solution of DL-histidine and succinic acid in 1:3 molar pr...
Two new salts 2-phenyl imidazolium hydrogen cyclobutane-1,1-dicarboxylate 1, imidazolium hydrogen ma...
Co-crystallization is the supramolecular combination of two or more different chemical entities in a...
High throughput of cocrystals furnishes information on the proximity of an Active Pharmaceutical Ing...
The title compound, C5H9NO4, crystallized as a zwitterion. There is an intramolecular N—H...O hydrog...
Neutral or charge-assisted hydrogen bonds occurring between organic molecules represent strong and d...
A series of three 5,5â²-substituted hydantoin derivatives (1-3) were synthesized, and their crystal ...
Three new pharmaceutical co-crystals: 1 PZA-MA (malonic acid), 2 PZA-SA (succinic acid, a new polymo...
The reaction of CoCl2 with succinic acid and isonicotinamide in basic solution produces the title co...
In the last years, the design and synthesis of co-crystals containing active pharmaceutical ingredi...
In the context of pharmaceutical development, it is abundantly clear that there is a need for greate...
The title compound, C11H3I3N4O4 center dot C2H6O, crystallizes in the triclinic P (1) over bar space...
DL-Proline hemisuccinic acid, C5H9NO2.1/2C4H6O4, M(r) = 174.2, P2(1/c) a = 5.254 (1), b = 17.480 (1)...
The combination of racemic praziquantel, (<i>RS</i>)-PZQ, with aliphatic dicarboxylic acids of the h...
R factor = 0.034; wR factor = 0.095; data-to-parameter ratio = 19.0. The title compound, C12H14N2O3S...
Diffusion of acetonitrile into an aqueous solution of DL-histidine and succinic acid in 1:3 molar pr...
Two new salts 2-phenyl imidazolium hydrogen cyclobutane-1,1-dicarboxylate 1, imidazolium hydrogen ma...
Co-crystallization is the supramolecular combination of two or more different chemical entities in a...
High throughput of cocrystals furnishes information on the proximity of an Active Pharmaceutical Ing...
The title compound, C5H9NO4, crystallized as a zwitterion. There is an intramolecular N—H...O hydrog...
Neutral or charge-assisted hydrogen bonds occurring between organic molecules represent strong and d...
A series of three 5,5â²-substituted hydantoin derivatives (1-3) were synthesized, and their crystal ...
Three new pharmaceutical co-crystals: 1 PZA-MA (malonic acid), 2 PZA-SA (succinic acid, a new polymo...
The reaction of CoCl2 with succinic acid and isonicotinamide in basic solution produces the title co...
In the last years, the design and synthesis of co-crystals containing active pharmaceutical ingredi...
In the context of pharmaceutical development, it is abundantly clear that there is a need for greate...
The title compound, C11H3I3N4O4 center dot C2H6O, crystallizes in the triclinic P (1) over bar space...
DL-Proline hemisuccinic acid, C5H9NO2.1/2C4H6O4, M(r) = 174.2, P2(1/c) a = 5.254 (1), b = 17.480 (1)...
The combination of racemic praziquantel, (<i>RS</i>)-PZQ, with aliphatic dicarboxylic acids of the h...
R factor = 0.034; wR factor = 0.095; data-to-parameter ratio = 19.0. The title compound, C12H14N2O3S...
Diffusion of acetonitrile into an aqueous solution of DL-histidine and succinic acid in 1:3 molar pr...